Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) traded down 1.8% on Friday . The stock traded as low as $5.48 and last traded at $5.56. 4,296,055 shares were traded during mid-day trading, a decline of 7% from the average session volume of 4,594,854 shares. The stock had previously closed at $5.66.
Analysts Set New Price Targets
A number of research analysts recently issued reports on TLRY shares. ATB Cormark Capital Markets dropped their target price on shares of Tilray Brands from $9.50 to $9.00 and set a "sector perform" rating on the stock in a research report on Thursday, April 2nd. Roth Mkm raised shares of Tilray Brands from a "neutral" rating to a "buy" rating and set a $10.00 price target for the company in a research note on Thursday, April 2nd. Wall Street Zen upgraded shares of Tilray Brands from a "sell" rating to a "hold" rating in a report on Saturday, March 21st. Zacks Research raised shares of Tilray Brands from a "strong sell" rating to a "hold" rating in a research report on Wednesday, February 11th. Finally, TD Cowen reduced their target price on Tilray Brands from $10.00 to $7.00 and set a "buy" rating for the company in a research note on Monday, March 30th. Three research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Tilray Brands presently has a consensus rating of "Hold" and an average price target of $11.50.
Get Our Latest Stock Report on Tilray Brands
Tilray Brands Stock Performance
The stock has a market cap of $648.01 million, a price-to-earnings ratio of -0.41 and a beta of 1.94. The company's fifty day simple moving average is $6.80 and its two-hundred day simple moving average is $8.80. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The business had revenue of $206.73 million for the quarter, compared to analyst estimates of $201.35 million. During the same quarter in the prior year, the business earned ($0.87) earnings per share. On average, analysts forecast that Tilray Brands, Inc. will post -0.58 earnings per share for the current year.
Insider Transactions at Tilray Brands
In other Tilray Brands news, Director David G. Hopkinson sold 33,556 shares of the business's stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total transaction of $232,878.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.84% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the stock. Silverlake Wealth Management LLC bought a new stake in Tilray Brands during the third quarter worth $25,000. Oppenheimer & Co. Inc. bought a new stake in shares of Tilray Brands during the 3rd quarter worth $25,000. Unified Investment Management bought a new stake in Tilray Brands during the third quarter worth about $26,000. Y Intercept Hong Kong Ltd purchased a new position in Tilray Brands in the 3rd quarter worth $30,000. Finally, HighPoint Advisor Group LLC purchased a new stake in Tilray Brands during the 3rd quarter valued at $33,000. Hedge funds and other institutional investors own 9.35% of the company's stock.
About Tilray Brands
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
